sulfadiazine has been researched along with Prostatic Hyperplasia in 2 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SCHMELZ, W | 1 |
| Riedmiller, H | 1 |
| Vergin, H | 1 |
| Jacobi, GH | 1 |
2 other studies available for sulfadiazine and Prostatic Hyperplasia
| Article | Year |
|---|---|
[Clinical experiences with solu-supronal with special reference to coli infections in cystitis and prostate hypertrophy].
Topics: Cystitis; Drug Combinations; Escherichia coli; Escherichia coli Infections; Humans; Hypertrophy; Mal | 1953 |
[Diffusion of co-tetroxazin into prostatic tissue (author's transl)].
Topics: Diffusion; Drug Combinations; Humans; Male; Prostate; Prostatic Hyperplasia; Pyrimidines; Sulfadiazi | 1981 |